Advertisement
Australia markets closed

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • AUD/USD

    0.6426
    0.0000 (-0.00%)
     

  • OIL

    82.99
    +0.26 (+0.31%)
     

  • GOLD

    2,399.60
    +1.60 (+0.07%)
     

  • Bitcoin AUD

    100,974.80
    +3,721.55 (+3.83%)
     

  • CMC Crypto 200

    1,330.02
    +17.40 (+1.33%)
     

  • AUD/EUR

    0.6019
    -0.0011 (-0.19%)
     

  • AUD/NZD

    1.0888
    +0.0013 (+0.12%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,345.07
    -49.24 (-0.28%)
     

  • FTSE

    7,831.72
    -45.33 (-0.58%)
     

  • Dow Jones

    37,931.26
    +155.88 (+0.41%)
     

  • DAX

    17,720.42
    -116.98 (-0.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

United States Asthma Market and Competitive Landscape Report 2021

Research and Markets
·2-min read

Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Asthma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

US Asthma Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Asthma pipeline products, Asthma epidemiology, Asthma market valuations and forecast, Asthma drugs sales and competitive landscape in the US.

The research is classified into seven sections - Asthma treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Asthma pipeline: Find out the products in clinical trials for the treatment of Asthma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products

  • Asthma epidemiology: Find out the number of patients diagnosed (prevalence) with Asthma in the US

  • Asthma drugs: Identify key products marketed and prescribed for Asthma in the US, including trade name, molecule name, and company

  • Asthma drugs sales: Find out the sales revenues of Asthma drugs in the US

  • Asthma market valuations: Find out the market size for Asthma drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026

  • Asthma drugs market share: Find out the market shares for key Asthma drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Asthma market analysis and sales trends

  • Track competitor drugs sales and market share in the US Asthma market

  • Track competitive developments in Asthma market and present key issues and learnings

  • Synthesize insights for Asthma market and products to drive business performance

  • Answer key business questions about the Asthma market

  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Asthma products

  • Supports decision making in R&D to long term marketing strategies

ADVERTISEMENT

Key Topics Covered:

1) Asthma Treatments

2) Asthma Pipeline

3) US Asthma Epidemiology

4) Marketed Drugs for Asthma in US

5) US Asthma Market Size and Forecast

6) US Asthma Products Sales and Forecast

7) US Asthma Market Competitive Landscape

8) Methodology

For more information about this report visit https://www.researchandmarkets.com/r/7w8kz9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900